The president-elect said he will issue an executive order Monday to delay the ban while he brokers a sale. The app has returned on web and mobile, but is not available in Apple and Google's stores.

The app had more than 170 million monthly users in the U.S. The black-out is the result of a law forcing the service offline unless it sheds its ties to ByteDance, its China-based parent company.

The Supreme Court will hear a case on gender-affirming care in the next term after a flurry of legislation. Lower courts have come to conflicting conclusions when these bans were challenged.

The Supreme Court will consider the question: Should doctors treating pregnancy complications follow state or federal law if the laws conflict? Here's how the case could affect women and doctors.

The case could affect not just abortion access, but oversight of the drug industry and the authority of federal agencies. The court hears arguments Tuesday.

Key court decisions in 2024 about prescription drug prices, abortion bans, gender-affirming care and the Affordable Care Act could change the way health care is delivered in America.

The court's action sets up a collision between the Food and Drug Administration's 23-year study and supervision of mifepristone, and the circumstances under which it can be prescribed.

Sandra Day O'Connor was called "the most powerful woman in America" during her quarter of a century as a Supreme Court justice.

An Indiana school district is asking the U.S. Supreme Court to review a case concerning a student’s right to use the bathroom that aligns with their gender identity.

Voters in Ohio, Virginia and Kentucky signaled support for abortion rights, even where it wasn't directly on the ballot, more than a year after the Supreme Court rolled them back.